Page 9 - SRNS_2015_Annual_Report
P. 9
To see videos of our SRNL missions, please click on the globe, or visit
www.savannahrivernuclearsolutions.com/annual
Lab Director of the Year Innovative solutions
SRNL’s Dr. Terry Michalske was named SRNL’s Dr. Aaron Washington (right)
National Lab Director of the Year by DOE for briefs Energy Secretary Ernest Moniz
work encouraging small businesses at SRNL. on research that’s led to a new
He was cited for “collaborative approaches to radiation resistant polymer coating
engage small business to help the lab perfect for containment bags—another
technology in the nuclear environment.” illustration of a cost-saving, efficient
innovation SRNL is bringing to DOE’s
Advanced Manufacturing Facility legacy waste cleanup mission.
SRNL has begun the pursuit of a new Partnering
Advanced Manufacturing Collaborative with regional universities
Facility, a proposed public/private
partnership that will build on the growing The SRNS Board of Directors has pledged
number of advanced manufacturing $400,000 towards an SRNL University
partnerships already under way, create new Scholars program, a program that will
jobs in the region and develop the future provide scholarship aid and expose
workforce. Occupancy is expected in 2018. regional science and technology students
to the research staff at SRNL. Signing the
Partnering University Scholars Program agreement
to commercialize technology were (pictured above, from left) SRNS
President and CEO Carol Johnson; USCA
SRNL’s patented hydrogen isotope Chancellor Dr. Sandra Jordan; SRNS
separation process has been licensed by Executive Vice President and SRNL Director
SHINE Medical Technologies, an example Dr. Terry Michaske; and SRNS Board of
of how SRNL’s tritium expertise is being Directors Chairman Bruce Stanski.
leveraged to help solve the global problem
of producing medical isotopes. Expanding missions
In a reflection of an expanding mission, in
2015 SRNL established a dedicated Office
of Hanford Mission Programs. SRNL’s
international work continues as well, most
notably with ongoing consulting on technical
issues at Japan’s damaged Fukushima
Daiichi Nuclear Plant.
Since 2008, SRNL has executed 30 license
agreements to transfer Lab-developed
technologies for commercial use.
7
